Binding of the antiretroviral drug, d-aspartate- -hydroxamate on the NMDA receptor

Author： Chaudieu I.   Vila J.   Hamedi-Sangsari F.   Privat A.   Vignon J.  

Publisher： Elsevier

ISSN： 1382-6689

Source： Environmental Toxicology and Pharmacology, Vol.2, Iss.4, 1996-12, pp. : 367-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

N-Methyl-D-Aspartate Receptor (NMDA) Antagonists as Potential Pain Therapeutics

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-04 ,pp. : 749-770

Bentham Science Publishers

Access to resources Recommend Favorite

The role of N-Methyl-D-Aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

By Heresco-Levy U.   Javitt D.C.  

European Neuropsychopharmacology, Vol. 8, Iss. 2, 1998-05 ,pp. : 141-152

Elsevier

Access to resources Recommend Favorite

Potential and Current Use of N -Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging

By Le D.A.  

Drugs & Aging, Vol. 18, Iss. 10, 2001-10 ,pp. : 717-724

Adis International

Access to resources Recommend Favorite

A novel NMDA receptor antagonist protects against N-methyl-d-aspartate- and glutamate-induced neurotoxicity in the goldfish retina

By Tyan S.-H.   Sue T.-Y.   Hon Y.-S.   Gean P.-W.   Chang Y.-C.  

European Journal of Pharmacology, Vol. 321, Iss. 2, 1997-02 ,pp. : 171-179

Elsevier

Access to resources Recommend Favorite

Striatal NMDA receptor subtypes: the pharmacology of N-methyl-d-aspartate-evoked dopamine, -aminobutyric acid, acetylcholine and spermidine release

By Nankai M.   Fage D.   Carter C.  

European Journal of Pharmacology, Vol. 286, Iss. 1, 1995-11 ,pp. : 61-70

Elsevier

Access to resources Recommend Favorite